Radiogenomics in Renal Cancer Management—Current Evidence and Future ProspectsMatteo Ferro, Octavian Sabin Tătaru, Gennaro Musi et al.|International Journal of Molecular Sciences|2023Cited by 124
Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature reviewMatteo Ferro, Octavian Sabin Tătaru, Stefano Luzzago et al.|Therapeutic Advances in Urology|2023Cited by 103
Molecular Imaging Diagnosis of Renal Cancer Using 99mTc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel TechniquesOctavian Sabin Tătaru, Matteo Ferro, Michele Marchioni et al.|Diagnostics|2023Cited by 37
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)Alessandro Tafuri, Alessandro Antonelli, Michele Marchioni et al.|World Journal of Urology|2022Cited by 34
The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort AnalysisMatteo Ferro, Emanuele Zaffuto, Francesco Del Giudice et al.|Cancers|2021Cited by 33